NEW YORK — Stilla Technologies expects that its new six-color digital PCR system, the first of its kind, will find use in a variety of applications, including oncology, infectious disease testing and monitoring GMOs.
The launch of the company's Prism system earlier this month should support the development of an accompanying menu of tests to serve diverse users, according to CEO Rémi Dangla.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
